Advanced clinical
Decentralized clinical trials are here to stay. Explore both their advantages and their challenges from an operational perspective. Tune in now as experts share their perspectives on:
⦁ The enduring, post-COVID benefits of the decentralized model
⦁ Operational-level challenges
⦁ Sponsor considerations in decentralized trials
⦁ Trial management concerns
⦁ Predictions for the future of decentralized studies
Open Media
Enjoyed this podcast? Find part one here
Advanced clinical
The UK major's asthma drug gets a key expanded approval.
Updated Phase II results from petosemtamab have impressed ahead of ASCO, outshining Keytruda monotherapy and its bispecific rival from Bicara.
The German company has big plans for the next five years or so. Scrip speaks to its chief medical officer Lykke Hinsch Gylvin about how it is using AI and other innovative approaches to make good on its ambitions.
The French drugmaker is expanding its neurology activities with the $470m deal.
Delve into the challenges facing the NHS, from rising medicine costs to supply shortages, and how generics and branded generics can provide solutions for a more sustainable healthcare system
Access key stats from biotechs on the latest trends impacting oncology R&D, including therapeutic pipelines and clinical trial challenges, AI/ML, and a future outlook on innovation.
Gain exclusive insights into the biggest challenges biotechs face in oncology and uncover the latest opportunities to accelerate drug development.
Learn about the critical role the right CRO plays in successfully navigating the significant drug development opportunities in Japan.